Drugs & Targets FDA grants priority review of belantamab mafodotin for relapsed or refractory multiple myeloma January 24, 2020Vol.46 No.04
Drugs & Targets Myriad submits sPMA for BRACAnalysis CDx as companion diagnostic for Lynparza in metastatic castration-resistant prostate cancer January 24, 2020Vol.46 No.04
Drugs & Targets Health Canada approves Keytruda + Inlyta for advanced RCC January 24, 2020Vol.46 No.04
Clinical Roundup Surufatinib phase III study reaches primary endpoint in advanced pancreatic neuroendocrine tumors in China, trial to end early January 24, 2020Vol.46 No.04
Clinical Roundup Pain control strategy reduces need for opioids in patients with head and neck cancer January 24, 2020Vol.46 No.04
Drugs & Targets 9/11 responders have increased overall cancer incidence in thyroid, prostate, and leukemia cancers, study finds January 24, 2020Vol.46 No.04
In Brief University of Maryland joins Big Ten Cancer Research Consortium January 24, 2020Vol.46 No.04
In Brief Victor Dzau elected NAM president for second term, Carlos del Rio named next foreign secretary January 24, 2020Vol.46 No.04
